𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD

✍ Scribed by McClorey, G; Moulton, H M; Iversen, P L; Fletcher, S; Wilton, S D


Book ID
110039850
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
362 KB
Volume
13
Category
Article
ISSN
0969-7128

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Improved antisense oligonucleotide induc
✍ Christopher J. Mann; Kaite Honeyman; Graham McClorey; Sue Fletcher; Stephen D. W πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 299 KB

## Abstract ## Background Duchenne muscular dystrophy (DMD) is a fatal genetic disorder caused by dystrophin gene mutations that preclude synthesis of a functional protein. One potential treatment of the disorder has utilised antisense oligoribonucleotides (AOs) to induce removal of disease‐associ

Towards a therapeutic inhibition of dyst
✍ Ian R. Graham; Vanessa J. Hill; Muthiah Manoharan; Gopal B. Inamati; George Dick πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 424 KB

## Abstract ## Background The activity of synthetic antisense oligonucleotides (splicomers) designed to block pre‐mRNA splicing at specific exons has been demonstrated in a number of model systems, including constitutively spliced exons in mouse dystrophin RNA. Splicomer reagents directed to Duche